These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3318029)

  • 1. Positive immunohematologic and serologic test results due to high-dose intravenous immune globulin administration.
    Garcia L; Huh YO; Fischer HE; Lichtiger B
    Transfusion; 1987; 27(6):503. PubMed ID: 3318029
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immune globulin therapy for antibody immunodeficiency.
    Savéry F
    Clin Ther; 1984; 7(1):69-72. PubMed ID: 6518465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-dose intravenous immunoglobulins in the treatment of immune blood cytopenia. Mechanisms of action, indications and results].
    Aymard JP; Ferry R; Janot C; Schooneman F; Streiff F
    Ann Med Interne (Paris); 1990; 141(8):689-97. PubMed ID: 2091513
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful intravenous immune globulin therapy for human immunodeficiency virus-associated thrombocytopenia.
    Pollak AN; Janinis J; Green D
    Arch Intern Med; 1988 Mar; 148(3):695-7. PubMed ID: 3277573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immune globulin for the treatment of presumed quinidine-induced thrombocytopenia.
    Ray JB; Brereton WF; Nullet FR
    DICP; 1990; 24(7-8):693-5. PubMed ID: 1695793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successes and failures of intravenous immunoglobulin.
    Atrah HI; Crawford RJ; Gabra GS; Mitchell R
    Scand J Haematol; 1985 Apr; 34(4):345-7. PubMed ID: 4001865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and uses of intravenous immune globulin in primary ond secondary immune deficiency disorders. Naples, Florida, October 13-14, 1988.
    J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):565-648. PubMed ID: 2794300
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.
    Pollack M
    J Infect Dis; 1983 Jun; 147(6):1090-8. PubMed ID: 6406615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous immunoglobulins in pediatrics].
    Fontán G
    An Esp Pediatr; 1986 Aug; 25(2):77-9. PubMed ID: 3752750
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study.
    Lerman Y; Shohat T; Ashkenazi S; Almog R; Heering SL; Shemer J
    Clin Infect Dis; 1993 Sep; 17(3):411-4. PubMed ID: 8218682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal hepatitis B immunization: the dose of HBIg that should be administered at birth.
    Vegnente A; Iorio R; de Rosa E
    Pediatrics; 1994 Aug; 94(2 Pt 1):242-3. PubMed ID: 8080550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Do immunoglobulins have a value and a future in the treatment of severe bacterial infections?].
    Baumgartner JD
    Presse Med; 1990 Feb; 19(5):196-8. PubMed ID: 2137913
    [No Abstract]   [Full Text] [Related]  

  • 13. Caffey disease responding to high-dose immunoglobulin.
    Berthier M; Bonneau D; Huret JL
    Eur J Pediatr; 1988 May; 147(4):443-4. PubMed ID: 3294018
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of intravenous immune globulin in immunodeficiency diseases.
    Buckley RH; Schiff RI
    N Engl J Med; 1991 Jul; 325(2):110-7. PubMed ID: 2052044
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclic thrombocytopenia treated by high-dose intravenous immunoglobulin with a favorable response].
    Aoki Y; Fujisawa K; Ikegami M; Ishitoya N; Akatsuka J
    Rinsho Ketsueki; 1988 May; 29(5):705-10. PubMed ID: 3216497
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunoglobulins and immune deficiency: methods of administration].
    Suarez F
    Rev Med Interne; 2005 Oct; 26 Spec No 1():25-8. PubMed ID: 16475260
    [No Abstract]   [Full Text] [Related]  

  • 17. Passive transfer of HIV antibody by hepatitis B immune globulin.
    Schlech WF; Lee SH; Cook J; Rozee KR; MacIntosh N
    JAMA; 1989 Jan; 261(3):411-3. PubMed ID: 2909781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulin for multiple sclerosis.
    Yan J; Richert JR; Sirdofsky MD
    Lancet; 1990 Sep; 336(8716):692. PubMed ID: 1975879
    [No Abstract]   [Full Text] [Related]  

  • 19. Newer uses of intravenous immunoglobulins as anti-infective agents.
    Pennington JE
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1463-6. PubMed ID: 2221853
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.
    National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group
    N Engl J Med; 1991 Jul; 325(2):73-80. PubMed ID: 1675763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.